John Reed, M.D., Ph.D.

EVP, Pharmaceuticals, Research & Development

Johnson & Johnson Innovative Medicine

Mike Varney

Former Exectutive VP, Genentech Research & Early Development, Genentech

Mira Chaurushiya, Ph.D.

Managing Director

Westlake Village BioPartners

Ben Cravatt, Ph.D.

Professor & Gilula Chair, Chemical Biology

The Scripps Research Institute

Marianne De

CEO, Vir Biotechnology

Steve Bartz

Vice President Corporate Development, Seattle Genetics

Daniel Estes, Ph.D.

General Partner

Frazier Healthcare Partners

Stephen Ferruolo, J.D., Ph.D.

Secretary, Professor

USD School of Law

Rusty Gage

President, Salk Institute

Carol Gallagher

Venture Advisor, New Enterprise Associates, Inc. (NEA)

Kevin Grimes

Professor of Chemical and Systems Biology; Co-director of the SPARK Program at Stanford University School of Medicine

Jeff Hatfield

CEO, Vividion

Grace Han McMahon

AVP and Head, Pacific BD&L

Merck

Katie Hewitt

Chief Business Officer, Lilly New Ventures at Eli Lilly and Company

Richard Heyman, Ph.D.

Venture Partner

ARCH Ventures

John Hood, Ph.D.

Founder, CEO & Executive Chairman

Endeavor BioMedicines

Mike Jung

Distinguished Professor of Chemistry, UCLA

Chau Quang Khuong

General Partner and Senior Advisor, Catalio Capital Management

Scott Lippman

Distinguished Professor of Medicine, Director of the Moores Cancer Center, Chugai Pharmaceutical Chair, and Associate Vice Chancellor at UC San Diego School of Medicine

Stefan Luzi

Partner, Gilde Healthcare

Carole Nuechterlein

Head

Roche Venture Fund

Scott Platshon

Partner, EcoR1 Capital, LLC

Armin Rump

Director of Global Business Development, Otsuka

Camille Samuels

Director

Venrock Boards

Jay Stamatis

Vice President, Head of Business Development and Acquisitions

AbbVie

Matt Tremblay, Ph.D.

Chief Executive Officer

Blackbird Laboratories

Lesley Stolz, Ph.D.

Head, JLABS California

Alex Szidon, PhD

Chief Business Officer, Resilience

Jeffrey Warmke, PhD

Senior Vice President, Search and Evaluation & Alliance Management, Global Business Development, Daiichi Sankyo

Asish Xavier, Ph.D.

Vice President, Venture Investments

Johnson & Johnson Innovation – JJDC